Skip to content

Wearable Devices on Health Promotion in Diabetes

The Effectiveness of Wearable Devices on Health Promotion in Individuals With Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07144774
Enrollment
9
Registered
2025-08-27
Start date
2024-02-14
Completion date
2024-08-29
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes (DM)

Brief summary

This proposed study involves human participants who will be prospectively randomized into either 1) intervention group with a activity tracker or 2) control group without an activity tracker. In addition, the proposed study is designed to evaluate the effect of using an activity tracker on cardiovascular health in the study participants.

Interventions

DEVICEFitbit wrist-worn Inspire 2® activity tracker (Fitbit Inc., San Francisco, CA, USA)

Visual feedback of the physical activity level

Sponsors

Pacific University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. diagnosed with type 2 diabetes (HbA1c ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dL) 3. willing to link a fitness tracker (Fitbit®) App to their own smartphone

Exclusion criteria

1. are unable to walk without assistive devices, 2. are current smokers, 3. are pregnant or breastfeeding, 4. already engage in ≥ 150 minutes of moderate-to-vigorous physical activity per week, 5. have any medical conditions (e.g., musculoskeletal diseases, cognitive dysfunction) that will interfere with physical activity, 6. undergo any insulin treatment.

Design outcomes

Primary

MeasureTime frameDescription
Subendocardial viability ratio4 weeksThe subendocardial viability ratio (SEVR) was measured as an index of myocardial perfusion and coronary supply-demand balance, using applanation tonometry (SphygmoCor®, AtCor Medical, Sydney, Australia).
Time spent in physical activity and sedentary behaviors4 weeksTime (hours : minutes) spent in physical activity and sedentary behaviors in a week was collected using the Global Physical Activity Questionnaire (GPAQ). The GPAQ consists of 16 questions designed to estimate an individual's level of physical activity in 3 domains (work, transport, and recreational activities) and time spent in sedentary behavior.
Blood pressure4 weeksBrachial systolic and diastolic blood pressure (mmHg) was collected using an automated sphygmomanometer. Pulse pressure and mean arterial pressure were calculated from systolic and diastolic blood pressure.
Augmentation index4 weeksAugmentation index (%), as an indicator of arterial stiffness, was assessed using applanation tonometry (SphygmoCor®, AtCor Medical, Sydney, Australia).
Pulse wave velocity4 weeksPulse wave velocity (meter/second), as an arterial stiffness indicator, was assessed using applanation tonometry (SphygmoCor®, AtCor Medical, Sydney, Australia).
Step Counts4 weeksDaily step counts (steps/day) were collected using the activity tracker and mobile app.
Walking distance4 weeksDaily walking distance (meters/day) was collected using the activity tracker and mobile app.
Energy expenditure4 weeksDaily energy expenditure (calories/day) was collected using the activity tracker and mobile app.

Secondary

MeasureTime frameDescription
Metabolic measures4 weeksFasting glucose level
Body mass index4 weeksBody weight (kilograms) and height (meters) were measured and used to calculate body mass index (kg/m\^2).
Waist-to-hip ratio4 weeksWaist and hip circumferences (centimeters) were measured and used to calculate the waist-to-hip ratio.

Other

MeasureTime frameDescription
Quality of life via survey4 weeksThe quality of life was assessed using the 36-Item Short Form Health Survey (SF-36). The SF-36 consists of eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. All items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026